Neurogene (NGNE) Free Cash Flow (2018 - 2025)
Historic Free Cash Flow for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to -$19.6 million.
- Neurogene's Free Cash Flow fell 2473.0% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$78.4 million, marking a year-over-year decrease of 1064.07%. This contributed to the annual value of -$71.4 million for FY2024, which is 3801.09% down from last year.
- Per Neurogene's latest filing, its Free Cash Flow stood at -$19.6 million for Q3 2025, which was down 2473.0% from -$19.6 million recorded in Q2 2025.
- In the past 5 years, Neurogene's Free Cash Flow ranged from a high of -$9.4 million in Q2 2023 and a low of -$21.8 million during Q1 2024
- In the last 3 years, Neurogene's Free Cash Flow had a median value of -$17.0 million in 2023 and averaged -$16.7 million.
- As far as peak fluctuations go, Neurogene's Free Cash Flow plummeted by 7295.89% in 2024, and later soared by 119.5% in 2025.
- Neurogene's Free Cash Flow (Quarter) stood at -$17.0 million in 2023, then dropped by 3.23% to -$17.6 million in 2024, then decreased by 11.56% to -$19.6 million in 2025.
- Its Free Cash Flow stands at -$19.6 million for Q3 2025, versus -$19.6 million for Q2 2025 and -$21.6 million for Q1 2025.